Orthofix International reported $-2.22M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Accuray USD 2.54M 6.49M Dec/2024
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 108K 1.65M Mar/2026
Dexcom USD 199.5M 67.8M Mar/2026
EDAP TMS EUR -5.01M 586K Sep/2025
Globus Medical USD 140.59M 21.63M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -4.62M 2.91M Mar/2026
J&J USD 5.24B 119M Mar/2026
Medtronic USD 1.14B 231M Dec/2025
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Orthofix International USD -2.22M 20.57M Dec/2025
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Smith & Nephew USD 293M 79M Dec/2025
STAAR Surgical USD -18.31M 27.19M Dec/2025
Stryker USD 745M 104M Mar/2026
Surmodics USD -5.32M 6.22M Jun/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -714.33M 305.44M Dec/2025
Veracyte USD 28.71M 12.44M Mar/2026
Zimmer Biomet Holdings USD 238.1M 98.8M Mar/2026